Skip to main content
Peter Embi, MD, Rheumatology, Nashville, TN

PeterJEmbiMDMS

Rheumatology Nashville, TN

Peter J. Embi, MD, MS

Dr. Embi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Embi's full profile

Already have an account?

Summary

  • Dr. Peter Embi is a biomedical informatician and rheumatologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from University of South Florida Morsani College of Medicine and has been in practice 20 years. He is experienced in rheumatology as well as biomedical informatics.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Rheumatology, 2002 - 2004
  • Oregon Health & Science University
    Oregon Health & Science UniversityResidency, Internal Medicine, 1997 - 2000
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 1997

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2002 - 2025
  • American Board of Internal Medicine Rheumatology
  • American Board of Preventive Medicine Clinical Informatics

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians
  • Fellow (FACMI) American College of Medical Informatics
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • National Study Confirms Breakthrough COVID Cases Are Less Severe Than COVID in Unvaccinated Adults
    National Study Confirms Breakthrough COVID Cases Are Less Severe Than COVID in Unvaccinated AdultsDecember 6th, 2022
  • Covid-19: mRNA Vaccine Protection Less Robust in Immunocompromised, Study Confirms
    Covid-19: mRNA Vaccine Protection Less Robust in Immunocompromised, Study ConfirmsNovember 4th, 2021
  • Two Doses of mRNA COVID Vax Not Enough for the Immunosuppressed
    Two Doses of mRNA COVID Vax Not Enough for the ImmunosuppressedNovember 2nd, 2021
  • Join now to see all

Grant Support

  • Evaluating Ehr-Based, Point-Of-Care Trial Recruitment Across Clinical SettingsNational Library Of Medicine2008–2010
  • Evaluation Of An Ehr-Based Clinical Trial Alert SystemNational Library Of Medicine2004–2006

Professional Memberships